1. Ball DW (2000) Medullary thyroid carcinoma. In: Wartofsky L (ed) Thyroid cancer. A comprehensive guide to clinical management. Humana Press, Totowa, N.J., pp 365–381
2. Baudin E, Schlumberger M, Lumbrosa J. et al. (1996) Octreotide scintigraphy in patients with differentiated thyroid carcinoma: contribution for patients with negative radioiodine scans. J Clin Endocrinol Metab 81: 2451–2544
3. Beierwaltes WH, Rabbini R, Dmuchowski C, Lloyd RV, Eyre P, Mallette S (1984) An analysis of “ablation of thyroid remnants” with 131I in 511 patients from 1947–1984. J Nucl Med 25: 1287–1293
4. Benua RS, Cicale NR, Sonenberg M (1962) The relation of radioiodine dosimetry to results and complications in the treatment of metastatic thyroid cancer. AJR 87: 171–182
5. Brendel AJ, Guyot M, Jeandot R, Lefolt G, Manicet G (1998) Thallium-201 imaging in the follow-up of differentiated thyroid carcinoma. J Nucl Med 29: 1515–1520